Effects of antilymphocytic serum on bacterial and viral infections and virus oncogenesis.
D000257:Adenoviridae Infections / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D006801:Humans; D007239:Infections / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D009164:Mycobacterium Infections / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology; D009858:Oncogenic Viruses / Q000276:immunology*; D011120:Polyomavirus / Q000276:immunology; D012190:Retroviridae / Q000276:immunology; D013210:Staphylococcus / Q000276:immunology; D013934:Thymectomy; D014777:Virus Diseases / Q000276:immunology*
D000961:Antilymphocyte Serum